Gorski, Stanislaw A.
Vogel, Jörg
Doudna, Jennifer A.
Article History
First Online: 15 February 2017
Competing interests
: J.A.D. is executive director of the Innovative Genomics Initiative at the University of California, Berkeley (UC Berkeley) and the University of California, San Francisco (UCSF). J.A.D. is a co-founder of Editas Medicine, Intellia Therapeutics and Caribou Biosciences and a scientific adviser to Caribou, Intellia, eFFECTOR Therapeutics and Driver. Funding has been received from the Howard Hughes Medical Institute (HHMI), the US National Institutes of Health, the US National Science Foundation, Roche, Pfizer, the Paul Allen Institute and the Keck Foundation. J.A.D. is employed by HHMI and works at the UC Berkeley. UC Berkeley and HHMI have patents pending for CRISPR technologies on which she is an inventor.